tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Keymed Biosciences Announces 2025 Annual General Meeting and Key Resolutions
Company AnnouncementsKeymed Biosciences Announces 2025 Annual General Meeting and Key Resolutions
5d ago
2162
Keymed Biosciences to Review Annual Results and Dividend
PremiumCompany Announcements
Keymed Biosciences to Review Annual Results and Dividend
2M ago
2162
Keymed Biosciences Gains Approval for Stapokibart in Allergic Rhinitis Treatment
PremiumCompany Announcements
Keymed Biosciences Gains Approval for Stapokibart in Allergic Rhinitis Treatment
3M ago
2162
Keymed Biosciences Licenses CM355 to Prolium for Global Development
PremiumCompany Announcements
Keymed Biosciences Licenses CM355 to Prolium for Global Development
3M ago
2162
Keymed Biosciences Secures Licensing Deal for CM313
PremiumCompany Announcements
Keymed Biosciences Secures Licensing Deal for CM313
4M ago
2162
Keymed Biosciences Gains NMPA Approval for Stapokibart
PremiumCompany AnnouncementsKeymed Biosciences Gains NMPA Approval for Stapokibart
4M ago
2162
Keymed Biosciences Relocates Hong Kong Headquarters
Premium
Company Announcements
Keymed Biosciences Relocates Hong Kong Headquarters
5M ago
2162
Keymed Biosciences’ CM336 Shows Promise in Myeloma Study
Premium
Company Announcements
Keymed Biosciences’ CM336 Shows Promise in Myeloma Study
5M ago
2162
Keymed Biosciences Expands Global Reach with CM336 Deal
PremiumCompany Announcements
Keymed Biosciences Expands Global Reach with CM336 Deal
6M ago
2162
Keymed Biosciences’ Stapokibart Wins Approval in China
PremiumCompany Announcements
Keymed Biosciences’ Stapokibart Wins Approval in China
8M ago
2162
Keymed Biosciences Faces Steep Revenue Decline
PremiumCompany Announcements
Keymed Biosciences Faces Steep Revenue Decline
8M ago
2162
Keymed Biosciences Schedules Crucial Financial Meeting
PremiumCompany Announcements
Keymed Biosciences Schedules Crucial Financial Meeting
9M ago
2162
Keymed Biosciences Strikes Global Licensing Deal
PremiumCompany AnnouncementsKeymed Biosciences Strikes Global Licensing Deal
10M ago
2162
Keymed Biosciences Shareholders Back All Resolutions
Premium
Company Announcements
Keymed Biosciences Shareholders Back All Resolutions
10M ago
2162
Keymed Biosciences Reveals Promising CM313 Study
Premium
Company Announcements
Keymed Biosciences Reveals Promising CM313 Study
11M ago
2162
Keymed’s Stapokibart Drug Advances with Priority Review
PremiumCompany Announcements
Keymed’s Stapokibart Drug Advances with Priority Review
11M ago
2162
Keymed Announces Positive Stapokibart Trial Results
PremiumCompany Announcements
Keymed Announces Positive Stapokibart Trial Results
11M ago
2162
Keymed Reports Promising Cancer Drug Results
PremiumCompany Announcements
Keymed Reports Promising Cancer Drug Results
11M ago
2162
Keymed Biosciences’ Stapokibart Gains Priority Review
PremiumCompany Announcements
Keymed Biosciences’ Stapokibart Gains Priority Review
12M ago
2162

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >